Leonteq Securities AG’s Regenxbio RGNX Stock Holding History

Leonteq Securities AG’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,934	Closed	-$360K	–	1081
2020 Q4	$360K	Buy	+7,934	New	+$277K	0.02%	464

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Leonteq Securities AG's RGNX Position: Q1 2021 in Review

Leonteq Securities AG sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 7,934 shares — an estimated $360K sold.

Leonteq Securities AG first reported a position in RGNX in Q4 2020 and held it in 1 quarter. The position peaked at $360K in Q4 2020. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

Leonteq Securities AG reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
Leonteq Securities AG sold 7,934 Regenxbio shares in Q1 2021, an estimated $360K.
Leonteq Securities AG first reported a position in Regenxbio in Q4 2020 and held it in 1 quarter.
Leonteq Securities AG's Regenxbio position peaked at $360K in Q4 2020.
184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on Leonteq Securities AG's 13F filing for Q1 2021, filed 26 Mar 2026.